202 related articles for article (PubMed ID: 24478226)
1. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
Buysschaert I; Sanidas E; Hasegawa T; Koo BK; Honda Y; Fitzgerald PJ; Verheye S
Catheter Cardiovasc Interv; 2014 Dec; 84(7):1062-70. PubMed ID: 24478226
[TBL] [Abstract][Full Text] [Related]
2. Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial.
Miyazawa A; Ako J; Hassan A; Hasegawa T; Abizaid A; Verheye S; McClean D; Neumann FJ; Grube E; Honda Y; Fitzgerald PJ
Catheter Cardiovasc Interv; 2007 Dec; 70(7):952-7. PubMed ID: 18044777
[TBL] [Abstract][Full Text] [Related]
3. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
[TBL] [Abstract][Full Text] [Related]
4. 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.
Verheye S; Agostoni P; Dubois CL; Dens J; Ormiston J; Worthley S; Trauthen B; Hasegawa T; Koo BK; Fitzgerald PJ; Mehran R; Lansky AJ
J Am Coll Cardiol; 2009 Mar; 53(12):1031-9. PubMed ID: 19298915
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery bifurcation narrowing treated by Axxess stent implantation: The CARINAX registry.
Briguori C; Donahue M; Visconti G; Focaccio A; Pennacchi M; Lucisano L; Stio R; Mancone M; Calcagno S; Di Palma V; Labalestra N; Signoriello G; Sardella G
Catheter Cardiovasc Interv; 2017 Mar; 89(4):E112-E123. PubMed ID: 27469063
[TBL] [Abstract][Full Text] [Related]
6. Comparative Case-Control analysis of a dedicated self-expanding Biolimus A9-eluting Bifurcation stent versus provisional or mandatory side branch intervention strategies in the treatment of coronary bifurcation lesions.
Ohlow MA; Farah A; Richter S; El-Garhy M; von Korn H; Lauer B
Catheter Cardiovasc Interv; 2017 Jul; 90(1):39-47. PubMed ID: 27651317
[TBL] [Abstract][Full Text] [Related]
7. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
8. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.
Dubois C; Bennett J; Dens J; De Cock D; Desmet W; Belmans A; Ughi GJ; Sinnaeve P; Vrolix M; D'hooge J; Adriaenssens T
EuroIntervention; 2016 Apr; 11(13):1457-67. PubMed ID: 25947278
[TBL] [Abstract][Full Text] [Related]
9. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial.
Grundeken MJ; Garcia-Garcia HM; Kumsars I; Lesiak M; Kayaert P; Dens J; Stella PR; de Winter RJ; Laak LL; Généreux P; Kaplan AV; Leon MB; Wykrzykowska JJ; Onuma Y; Serruys PW
Catheter Cardiovasc Interv; 2017 Feb; 89(2):E53-E63. PubMed ID: 27083384
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system.
Triantafyllis AS; Bennett J; Pagourelias E; McCutcheon K; Adriaenssens T; Sinnaeve PR; Desmet W; Dubois C
Cardiol J; 2018; 25(4):470-478. PubMed ID: 29240962
[TBL] [Abstract][Full Text] [Related]
11. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study.
Bartorelli AL; Trabattoni D; Almonacid A; Fabbiocchi F; Montorsi P; Galli S; Grancini L; Ravagnani P; Mintz GS; Kaplan AV; Popma JJ; Maehara A
Catheter Cardiovasc Interv; 2015 Mar; 85(4):544-53. PubMed ID: 25115944
[TBL] [Abstract][Full Text] [Related]
12. Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings.
Grube E; Buellesfeld L; Neumann FJ; Verheye S; Abizaid A; McClean D; Mueller R; Lansky A; Mehran R; Costa R; Gerckens U; Trauthen B; Fitzgerald PJ
Am J Cardiol; 2007 Jun; 99(12):1691-7. PubMed ID: 17560877
[TBL] [Abstract][Full Text] [Related]
13. Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study.
Buysschaert I; Dubois CL; Dens J; Ormiston J; Worthley S; McClean D; Ottervanger JP; Meredith I; Uren N; Wijns W; Whitbourn R; Mehran R; Lansky AJ; Bichalska M; Meis S; Verheye S
EuroIntervention; 2013 Sep; 9(5):573-81. PubMed ID: 24058075
[TBL] [Abstract][Full Text] [Related]
14. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
Bennett J; Adriaenssens T; Desmet W; Dubois C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents.
Waseda K; Ako J; Kume T; Fitzgerald PJ; Honda Y
J Invasive Cardiol; 2016 Aug; 28(8):323-9. PubMed ID: 26689416
[TBL] [Abstract][Full Text] [Related]
16. Impact of kissing balloon inflation on the main vessel stent volume, area, and symmetry after side-branch dilation in patients with coronary bifurcation lesions: a serial volumetric intravascular ultrasound study.
Rahman S; Leesar T; Cilingiroglu M; Effat M; Arif I; Helmy T; Leesar MA
JACC Cardiovasc Interv; 2013 Sep; 6(9):923-31. PubMed ID: 23954062
[TBL] [Abstract][Full Text] [Related]
17. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.
Diletti R; Farooq V; Girasis C; Bourantas C; Onuma Y; Heo JH; Gogas BD; van Geuns RJ; Regar E; de Bruyne B; Dudek D; Thuesen L; Chevalier B; McClean D; Windecker S; Whitbourn RJ; Smits P; Koolen J; Meredith I; Li X; Miquel-Hebert K; Veldhof S; Garcia-Garcia HM; Ormiston JA; Serruys PW
Heart; 2013 Jan; 99(2):98-105. PubMed ID: 23118346
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of biolimus A9-eluting stent for treatment of right coronary ostial lesion with intravascular ultrasound guidance: a multi-center registry.
Nasu K; Oikawa Y; Habara M; Shirai S; Abe H; Kadotani M; Gotoh R; Hozawa H; Ota H; Suzuki T; Shibata Y; Tanabe M; Nakagawa Y; Serikawa T; Nagasaka S; Takeuchi Y; Fujimoto Y; Tamura H; Kobori Y; Yajima J; Aizawa T; Suzuki T;
Cardiovasc Interv Ther; 2018 Oct; 33(4):321-327. PubMed ID: 28929334
[TBL] [Abstract][Full Text] [Related]
19. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
[TBL] [Abstract][Full Text] [Related]
20. Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial.
Yamasaki M; Tsujino I; Lima-Filho MO; Ako J; Shimohama T; Hasegawa T; Sakurai R; Sudhir K; Stone GW; Waseda K; Honda Y; Fitzgerald PJ
EuroIntervention; 2012 Oct; 8(6):724-31. PubMed ID: 23086791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
